SK Bioscience Co (XKRX:302440) Deferred Tax : ₩-42,633 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

SK Bioscience Co's change in deferred tax for the three months ended in Mar. 2025 was ₩-9,731 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-42,633 Mil.

SK Bioscience Co Deferred Tax Historical Data

The historical data trend for SK Bioscience Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Deferred Tax Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Deferred Tax

Get a 7-Day Free Trial

4,403.54

115,988.90

19,281.23

-14,990.49

-38,989.76

SK Bioscience Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Deferred Tax	Get a 7-Day Free Trial															-6,087.62	-5,492.19	-8,339.98	-19,069.97	-9,731.01

SK Bioscience Co Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-42,633 Mil.

SK Bioscience Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co Headlines

No Headlines